Targeting cerebrospinal fluid for discovery of brain cancer biomarkers

Abstract

Central nervous system (CNS) cancer is a devastating illness with unmet therapeutic needs. Establishing biomarkers that have the potential to guide accurate CNS cancer diagnosis or are helpful in predicting disease progression or therapy response is of great interest. Cerebrospinal fluid (CSF) has been extensively targeted for the detection of molecules that might be useful markers for cancer detection. However, so far very few of such markers have found a standardized routine clinical application. This review examines the current scientific knowledge about the biochemical elements in the CSF that have been reported in the literature as brain cancer biomarkers and highlight reasons why the role of most markers is not yet established in the managment of CNS tumors.

Keywords

Cerebrospinal fluid / central nervous system cancers / cerebrospinal fluid cytology / biochemical markers

References

[1] Nayak L,Wen PY.Epidemiology of brain metastases..Curr Oncol Rep2012;14:48-54

[2] Teplyuk NM,Gabriely G,Kim E,Kim RY,Pastorino S,Krichevsky AM.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity..Neuro Oncol2012;14:689-700 PMCID:PMC3367845

[3] Patel AS,Dicker DT,Sheehan JM,El-Deiry WS.Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases..Oncotarget2011;2:752-60 PMCID:PMC3248154

[4] Bonadio W.Pediatric lumbar puncture and cerebrospinal fluid analysis..J Emerg Med2014;46:141-50

[5] Brinker T,Morrison J.A new look at cerebrospinal fluid circulation..Fluids Barriers CNS2014;11:10 PMCID:PMC4016637

[6] Johanson CE,3rd,Brinker T,Silverberg GD.Multiplicity of cerebrospinal fluid functions: New challenges in health and disease..Cerebrospinal Fluid Res2008;5:10 PMCID:PMC2412840

[7] Machida A,Yokota T.Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases..Methods Mol Biol2013;1024:203-9

[8] Shen F,Yao Y,Zhang HS,Zhong P.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas..Neurosurg Rev2014;37:367-80; discussion 80

[9] Chamberlain M,Raizer J,Brandsma D,Taillibert S,Le Rhun E,van den Bent M,Jaeckle KA.Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials..Neuro Oncol2014;16:1176-85 PMCID:PMC4136900

[10] Chamberlain MC.Leptomeningeal metastasis..Curr Opin Oncol2010;22:627-35

[11] Patel AS,Dicker DT,Sheehan JM,El-Deiry WS.Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases..Oncotarget2014;2:752-60

[12] Gajjar A,Walter AW,Reardon DA,Jenkins JJ,Boyett JM,Heideman RL.Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors..J Clin Oncol1999;17:1825-8

[13] Grossman SA.Leptomeningeal carcinomatosis..Cancer Treat Rev1999;25:103-19

[14] Weston CL,Connor JR.Detection of cancer cells in the cerebrospinal fluid: current methods and future directions..Fluids Barriers CNS2011;8:14 PMCID:PMC3059292

[15] Singh G,Iyer VK.Cytopathology of neoplastic meningitis: A series of 66 cases from a tertiary care center..Cytojournal2013;10:13 PMCID:PMC3709425

[16] Fouladi M,Boyett JM,Thompson SJ,Jenkins JJ,Liu A,Heideman RL.Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor..J Clin Oncol1999;17:3234-7

[17] Terterov S,Bowen I.Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas..J Neurosurg Pediatr2010;6:131-6

[18] Nayak L,Gonzalez-Espinoza R,Panageas K,Liu CM,Omuro A.Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors..Neurology2013;80:1598-605; discussion 603

[19] Pan Z,Wang Y,Pang X,Shi W,Dong L.Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors..PLoS One2015;10:e0122016

[20] Bach F,Soletormos G,Horn T.Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer..Cancer1993;72:2376-82

[21] Chamberlain MC,Groves MD.Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment..Semin Oncol2009;36:S35-45

[22] Enting RH.Leptomeningeal neoplasia: epidemiology, clinical presentation, CSF analysis and diagnostic imaging..Cancer Treat Res2005;125:17-30

[23] Ahluwalia MS,Peereboom DM.Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time?.Cancer2012;118:1747-53

[24] Glantz MJ,Glantz LK,Mills P,Walters BC.Cerebrospinal fluid cytology in patients with cancer..Cancer1998;82:733-9

[25] Strik H,Nagel I,Bahr M.Automated cerebrospinal fluid cytology: limitations and reasonable applications..Anal Quant Cytol Histol2005;27:167-73

[26] Gomes HR.Cerebrospinal fluid approach on neuro-oncology..Arq Neuropsiquiatr2013;71:677-80

[27] Kim JH,Yoo YC,Park DB,An HJ,Cho KG.Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma..Med Sci Monit2011;18:BR450-60

[28] Okamoto H,Vortmeyer AO,Lee YS,Sohn TS,Ikejiri B,Mayer C,Oldfield EH.Comparative proteomic profiles of meningioma subtypes..Cancer Res2006;66:10199-204

[29] Vankalakunti M,Das Radotra B.MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas..Neuropathology2007;27:407-12

[30] Wulfkuhle JD,Steeg PS,3rd.Proteomic approaches to the diagnosis, treatment, and monitoring of cancer..Adv Exp Med Biol2003;532:59-68

[31] Kalinina J,Ritchie JC.Proteomics of gliomas: initial biomarker discovery and evolution of technology..Neuro Oncol2011;13:926-42 PMCID:PMC3158015

[32] Gollapalli K,Srivastava R,Singh P,Bajpai Dikshit J,Moiyadi A.Investigation of serum proteome alterations in human glioblastoma multiforme..Proteomics2012;12:2378-90

[33] Iwadate Y,Hiwasa T,Ishikura H,Yamaura A.Molecular classification and survival prediction in human gliomas based on proteome analysis..Cancer Res2004;64:2496-501

[34] Batabyal SK,Sengupta S,Chatterjee R.Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors..Neoplasma2003;50:377-9

[35] Moldrich G,Strik H.Carcinoembryonic antigen in the CSF of cancer patients--the value of intrathecal synthesis and correlation with IgA-diffusion dynamics..Acta Neurol Belg2010;110:314-20

[36] Nakagawa H,Murasawa A,Nakajima Y,Hayakawa T.Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis..No Shinkei Geka1991;19:1135-41(in Japanese)

[37] Nakagawa H,Murasawa A,Nakajima Y,Hayakawa T.Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors..J Neurooncol1992;12:111-20

[38] Wang P,Zhang X,Hao X.The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer..Cancer Biomark2013;13:123-30

[39] Khwaja FW,Mendrinos SE,Olson JJ,Van Meir EG,Brat DJ.Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers..Proteomics2006;6:6277-87

[40] Samuel N,Rutka JT,Malkin D.Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors..J Neurooncol2014;118:225-38

[41] Qaddoumi I,Li S,Pai-Panandiker A,Klimo P,Broniscer A.Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors..Childs Nerv Syst2012;28:1017-24 PMCID:PMC3526807

[42] Nishizaki T,Adachi N,Nakayama H,Ikeda N,Suzuki M.Detection of craniospinal dissemination of intracranial germ cell tumours based on serum and cerebrospinal fluid levels of tumour markers..J Clin Neurosci2001;8:27-30

[43] Watanabe S,Kikuno A,Komoda T,Amano K,Koyamaishi Y.A highly sensitive and specific chemiluminescent enzyme immunoassay for placental alkaline phosphatase in the cerebrospinal fluid of patients with intracranial germinomas..Pediatr Neurosurg2012;48:141-5

[44] Miyanohara O,Kaji M,Sawamura Y,Kuratsu J.Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors..J Neurosurg2002;97:177-83

[45] Ilhan-Mutlu A,Wohrer A,Marosi C,Preusser M.Blood alterations preceding clinical manifestation of glioblastoma..Cancer Invest2012;30:625-9

[46] Khwaja FW,Olson JJ,Gillespie GY,Groves MD,Pohl J.Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients..J Proteome Res2007;6:559-70 PMCID:PMC2566942

[47] Khwaja FW,Brat DJ.Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration..Clin Cancer Res2006;12:6331-6

[48] Sampath P,Sungarian A,Alderson L.Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma..Cancer Control2004;11:174-80

[49] Schuhmann MU,Nassimi R,Schneekloth CG,Selle H.Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme..Eur J Surg Oncol2010;36:201-7

[50] Ohnishi M,Nagashio R,Utsuki S,Okayasu I.Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein..Pathol Int2009;59:797-803

[51] Saratsis AM,Magge S,Perez J,Hwang E,Packer RJ.Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid..Neuro Oncol2012;14:547-60 PMCID:PMC3337313

[52] Galati D,Del Vecchio L.Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies..Leuk Res2013;37:231-7

[53] Huttner A.Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers..Hematol Oncol Clin North Am2012;26:715-32

[54] Le Rhun E,Chamberlain MC.Carcinomatous meningitis: Leptomeningeal metastases in solid tumors..Surg Neurol Int2013;4:S265-88

[55] Roy S,Fridlyand J,Kadoch C,Damon L,Kunwar S,Jones T,Schulman H.Protein biomarker identification in the CSF of patients with CNS lymphoma..J Clin Oncol2008;26:96-105 PMCID:PMC4134101

[56] Kuusisto ME,Remes AM,Karihtala P,Kuittinen O.Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma..Ann Hematol2015;94:1167-74 PMCID:PMC4432105

[57] Zetterberg H,Blennow K.CSF antithrombin III and disruption of the blood-brain barrier..J Clin Oncol2009;27:2302-3; author reply 3-4

[58] Brunn A,Strack A,Mawrin C,Deckert M.Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma..Acta Neuropathol2007;114:271-6

[59] Sasagawa Y,Tachibana O.Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system..J Neurooncol2015;121:177-83

[60] Rajagopal MU,MacDonald TJ,Gururangan S,Phillips P,Gordish-Dressman H.Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study..Proteomics2011;11:935-43 PMCID:PMC3088509

[61] Saso L,Sorrentino C,Silvestrini B,Li JC,Mruk D.Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor..Biochem Mol Biol Int1998;46:643-56

[62] Desiderio C,Rossetti DV,Giardina B,Massimi L,Di Rocco C.Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors..Proteomics2012;12:2158-66

[63] Figarella-Branger D,Chavin P,Gentet JC.Correlation between polysialic-neural cell adhesion meolecule levels in CSF and medulloblastoma outcomes..J Clin Oncol1996;14:2066-72

[64] Fedarko NS,Karadag A,Fisher LW.Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer..Clin Cancer Res2001;7:4060-6

[65] Kao CL,Ho DM,Liu RS,Tsai FT,Ku HH,Wong TT.Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor..Am J Clin Pathol2005;123:297-304

[66] de Bont JM,Reddingius RE,Passier MM,Pieters R.Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients..Int J Cancer2008;123:594-600

[67] de Bont JM,Reddingius RE,van Gool SW.Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients..Eur J Paediatr Neurol2008;12:334-41

[68] Albulescu R,Popescu ID,Necula LG,Teodoru M.Cytokine patterns in brain tumour progression..Mediators Inflamm2013;2013:979748 PMCID:PMC3707225

[69] Zhao G,Su X.Determination of S-100 beta protein in cerebrospinal fluid of patients with metastatic carcinoma to central nervous system..Zhonghua Nei Ke Za Zhi2000;39:732-4(in Chinese)

[70] Wang P,Zhang X,Hao X.The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer..Cancer Biomark2013;13:123-30

[71] Bakri Y,Berkowitz R.CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor..J Reprod Med2000;45:94-6

[72] de Bont JM,Reddingius RE,Passier M,Kros JM,Luider TH.Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling..Clin Chem2006;52:1501-9

[73] Groves MD,Puduvalli VK,Conrad CA,Weinberg J,Yung WK.Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma..J Neurooncol2009;94:229-34

[74] Bougel S,Gallagher G,Janzer RC.Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids..Clin Cancer Res2013;19:2216-23

[75] Chamberlain MC.Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology..Cancer2009;115:1941-6

[76] Shalaby T,Baumgartner M.MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons..Int J Mol Sci2014;15:21554-86 PMCID:PMC4264241

[77] Baraniskin A,Schlegel U,Deckert M,Maghnouj A,Reinacher-Schick A,Hahn SA.Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system..Blood2011;117:3140-6

[78] Baraniskin A,Schlegel U,Zollner H,Hahn S.Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma..Neuro Oncol2012;14:29-33 PMCID:PMC3245991

[79] Scott BJ,Tihan T,Josephson SA.A systematic approach to the diagnosis of suspected central nervous system lymphoma..JAMA Neurol2013;70:311-9 PMCID:PMC4135394

[80] Turner JD,Almefty KK,Porter R,Kalani MY.The many roles of microRNAs in brain tumor biology..Neurosurg Focus2010;28:E3

[81] Wei D,Li L,Liu Y,Zhang G.MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis..Mol Neurobiol2015;51:1452-61

[82] Shalaby T FG,Gerber NU,Grotzer MA.Detection and quantification of extracellular microRNAs in medulloblastoma..J Cancer Metastasis Treat2015;1:67-75

[83] Fuzery AK,Chan MM.Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges..Clin Proteomics2013;10:13 PMCID:PMC3850675

[84] Teunissen CE,Bennett JL,Brundin L,Franciotta D,Fleming JO,Hintzen RQ,Johnson MH,Kuhle J,Rajda C,Schmidt HK,Waubant E,Giovannoni G,Tumani H.A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking..Neurology2009;73:1914-22 PMCID:PMC2839806

[85] Phi JH,Wang KC,Kim IO,Kim CY,Kim IH.Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow..Neuro Oncol2011;13:334-44 PMCID:PMC3064600

[86] Ho CY,Huppman AR,Ali SZ.Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid..Cancer Cytopathol2015;123:123-35

[87] Parmar H,Bouffet E,Shroff M.Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors..Pediatr Radiol2006;36:126-32

[88] Zarovnaya EL,Hug EB,Cromwell LD,Fadul CE,Park JP,Perry A.Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature..J Neurooncol2007;84:49-55

[89] Hilden JM,Burger P,Janss A,Walter AW,Biegel JA.Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry..J Clin Oncol2004;22:2877-84

[90] Laurent VE,Solernou V,Gabri M,de Davila MT,Chantada GL.Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA..Eur J Cancer2013;49:2892-9

[91] Bakhshi S,Kashyap S.Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging..J Pediatr Hematol Oncol2011;33:e182-5

[92] Jennings MT,Hochberg F.Intracranial germ-cell tumors: natural history and pathogenesis..J Neurosurg1985;63:155-67

[93] Chang SM GA,Vogelbaum MA.Principles and practice of neuro-oncology..A multidisciplinary approach. Demos Medical Publishing, LLC, New York2011;

[94] Benesch M,Berthold F.Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH)..J Neurooncol2005;72:179-83

[95] Wagner S,Berthold F,Rutkowski S,Warmuth-Metz M,Pietsch T.Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas..Br J Cancer2006;95:991-7 PMCID:PMC2360717

[96] Walker DA PG,Taylor RE.Brain and spinal tumors of childhood.Abingdon, Oxon: CRC Press 2004

[97] Forst DA,Loeffler JS.Low-grade gliomas..Oncologist2014;19:403-13 PMCID:PMC3983820

[98] Sievert AJ.Pediatric low-grade gliomas..J Child Neurol2009;24:1397-408 PMCID:PMC2917804

[99] Moon JH,Jung S.Leptomeningeal Dissemination of a Low-Grade Brainstem Glioma without Local Recurrence..J Korean Neurosurg Soc2012;51:109-12 PMCID:PMC3322207

[100] Hukin J,Velasquez L,Allen J.Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors..Neuro Oncol2002;4:253-60 PMCID:PMC1920666

[101] Leach PA,Coope DJ,Kamaly-Asl ID.Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?.Br J Neurosurg2008;22:619-24

[102] Valadi H,Bossios A,Lee JJ.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells..Nat Cell Biol2007;9:654-9

[103] Hunter MP,Zhang X,Lee EJ,Xiao T,Lee ML,Nana-Sinkam SP,Marsh CB.Detection of microRNA expression in human peripheral blood microvesicles..PLoS One2008;3:e3694

[104] Mathivanan S,Simpson RJ.Exosomes: extracellular organelles important in intercellular communication..J Proteomics2010;73:1907-20

[105] Kosaka N,Ochiya T.Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis..Cancer Sci2010;101:2087-92

[106] Kosaka N,Yoshioka Y,Matsuki Y.Secretory mechanisms and intercellular transfer of microRNAs in living cells..J Biol Chem2010;285:17442-52 PMCID:PMC2878508

[107] Rubenstein JL,Kadoch C,Barajas R,Josephson SA,Douglas V,Kaplan LD,Cha S,Cinque P,Lowell C.CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma..Blood2013;121:4740-8 PMCID:PMC3674672

[108] Lai NS,Fang XG,Chen SS,Xu SS.Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma..Br J Cancer2015;112:1241-6 PMCID:PMC4385967

[109] Sasayama T,Nishihara M,Tanaka H,Miyake S,Hosoda K.Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)..Neuro Oncol2012;14:368-80 PMCID:PMC3280797

[110] Fischer L,Pfeiffer S,Volk HD,Widmann T.CXCL13 and CXCL12 in central nervous system lymphoma patients..Clin Cancer Res2009;15:5968-73

[111] Murase S,Andoh H,Shinoda J,Sakai N.Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients..Neurol Res2000;22:434-42

[112] Pantazis G,Krope K,Fend F,Schittenhelm J,Meyermann R.Cerebral low-grade lymphoma and light chain deposition disease: exceedingly high IgG levels in the cerebrospinal fluid as a diagnostic clue..Clin Neuropathol2010;29:378-83

[113] Yang H,Zhang Y,Deng Q,Xu X.Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases..J Mol Diagn2014;16:558-63

[114] Shnaper S,Brown DA,Migliavacca E,Ostermann S,Stupp R,de Tribolet N.Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome..Int J Cancer2009;125:2624-30

[115] Baraniskin A,Schlegel U,Zollner H,Hahn S.Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma..Neuro Oncol2012;14:29-33 PMCID:PMC3245991

[116] Teplyuk NM,Gabriely G,Kim E,Kim RY,Pastorino S,Krichevsky AM.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity..Neuro Oncol2012;14:689-700 PMCID:PMC3367845

[117] Shi R,Li XY,Li Y,Zhang CG,Li WB,Cheng SJ.Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients..Oncotarget2015;6:26971-81 PMCID:PMC4694967

[118] Drusco A,Lagana A,Fassan M,Antenucci A,Vicentini C,Alder H,Ammirati M,Luscri M,Zanesi N.A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies..Oncotarget2015;6:20829-39 PMCID:PMC4673232